Autonomic nervous modulation: early treatment for pulmonary artery hypertension
作者全名："Xueyuan, Liu; Yanping, Xu; Jiaoqiong, Guan; Yuehui, Yin"
作者地址："[Xueyuan, Liu; Yanping, Xu; Yuehui, Yin] Chongqing Med Univ, Affiliated Hosp 2, Dept Cardiol, Chongqing 401336, Peoples R China; [Jiaoqiong, Guan] Sichuan Univ, West China Hosp, Dept Neurol, Chengdu 401336, Sichuan, Peoples R China"
通信作者："Yuehui, Y (通讯作者)，Chongqing Med Univ, Affiliated Hosp 2, Dept Cardiol, Chongqing 401336, Peoples R China.; Jiaoqiong, G (通讯作者)，Sichuan Univ, West China Hosp, Dept Neurol, Chengdu 401336, Sichuan, Peoples R China."
来源：ESC HEART FAILURE
ESI学科分类：CLINICAL MEDICINE
WOS号：WOS:001126223900001
JCR分区：Q2
影响因子：3.2
年份：2023
卷号：
期号：
开始页：
结束页：
文献类型：Review; Early Access
关键词：Pulmonary artery hypertension; Right heart failure; Autonomic nervous system; Neuromodulation; Early treatment
摘要："Pulmonary artery hypertension (PAH) is a chronic vascular disease defined by the elevation of pulmonary vascular resistance and mean pulmonary artery pressure, which arises due to pulmonary vascular remodelling. Prior research has already established a link between the autonomic nervous system (ANS) and PAH. Therefore, the rebalancing of the ANS offers a promising approach for the treatment of PAH. The process of rebalancing involves two key aspects: inhibiting an overactive sympathetic nervous system and fortifying the impaired parasympathetic nervous system through pharmacological or interventional procedures. However, the understanding of the precise mechanisms involved in neuromodulation, whether achieved through medication or intervention, remains insufficient. This limited understanding hinders our ability to determine the appropriate timing and scope of such treatment. This review aims to integrate the findings from clinical and mechanistic studies on ANS rebalancing as a treatment approach for PAH, with the ultimate goal of identifying a path to enhance the safety and efficacy of neuromodulation therapy and improve the prognosis of PAH."
基金机构：
基金资助正文：
